goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

OB/GYN CCC Corner - Maternal Child Health for American Indians and Alaska Natives

August 2005 CCC Corner > From Your Colleagues

Abstract of the Month | From Your Colleagues | Hot Topics | Features   

From your colleagues

Sandy Haldane, HQE

New IHS Women’s Health Consultant and Advanced Practice Nurse Consultant

Please help me welcome CAPT Carolyn Aoyama to IHS Headquarters, Division of Nursing.

As the IHS Women’s Health Consultant Carolyn will represent the IHS on matters of women’s health, providing leadership and technical assistance on program development, implementation, evaluation, and policy.  As the Advanced Practice Nurse Consultant, Carolyn will provide leadership and technical expertise on matters pertaining to policy and standards of practice as they pertain to Nurse Practitioners, Certified Nurse Midwives, and Certified Registered Nurse Anesthetists.  Carolyn received her BSN from the University of WI, her MPH from Johns Hopkins and is also a Certified Nurse Midwife.  Carolyn began her nursing career in IHS as a PHN at Ft. Defiance.  Carolyn has worked as a CNM in the inner city of Baltimore and Phoenix and as the Maternal Child Health Consultant for the State of Alaska’s Department of Health and Social Services.  Subsequently she worked as an EIS Officer with the CDC, a Public Health Advisor in the Perinatal Care Program of HRSA’s Bureau of Primary Health Care (BPHC), Nurse Consultant for Mental Health/Substance Abuse Service (HRSA/BPHC/Division of Community and Migrant Health), a Community Health Center Project Officer with HRSA/BPHC, and most recently as a Nurse Consultant with HRSA/Bureau of Health Professions/Division of Nursing.  Carolyn can be reached at 301-443-1028 or in Suite 300 of the Reyes Building.

Public health approach to suicide prevention in an American Indian Tribal Nation

CONCLUSIONS: Data from this community-based approach document a remarkable downward trend-measured by both magnitude and temporal trends in the specifically targeted age cohorts-in suicidal acts. The sequential decrease in age-specific rates of suicide attempts and gestures is indicative of the program's success.

May PA et al Outcome evaluation of a public health approach to suicide prevention in an American Indian Tribal Nation. Am J Public Health. 2005 Jul;95(7):1238-44.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=15933239&dopt=Abstract

Healthy Native Communities Fellowship accepting applications for 2006

Designed to build the capacity for effective health promotion practices at the local level by increasing the knowledge, skills, and capacities of Tribal, IHS, and Urban Indian health workers and leaders. Deadline September 1, 2005 http://www.ihs.gov/hpdp

Cardiovascular Disease: The Kaw Nation and other minority populations

Cordelia Clapp: Minority Nurse Magazine http://www.minoritynurse.com/features/health/05-03-05e.html

Ruth Lagerberg, CNM, formerly ANMC

Fetal cardiac echogenic foci on routine obstetric sonogram

What is your recommendation for follow-up for the finding of fetal cardiac echogenic foci on routine ob sono?  Level II looking for other markers of trisomy 21 or fetal cardiac Doppler or no f/u necessary?  I am working at a community health center north of NYC - the nearest perinatologist is over an hour away and many of our patients have limited resources, including transportation difficulties.  Level II sonos are available locally.  Our back-up OBs differ on their opinion of f/u.  I did a lit search, but the literature differs on recommendations as well.

OB/GYN CCC Editorial comment:

As luck would have it, the Indian Health system has two resources to offer on these issues. There is a helpful FAQ, plus a free CEU /CME module

Q. What is the significance 2 nd trimester of ultrasound ( US) markers for Down syndrome?

A. If US markers are negative, then decrease the risk by serum testing in ~1/2.

http://www.ihs.gov/MedicalPrograms/MCH/M/documents/DSultra42205.doc

Prenatal Genetic Screening – Serum and Ultrasound - CEU /CME module

http://www.ihs.gov/MedicalPrograms/MCH/M/TM01.cfm

Sheila F. Mahoney CNM, NIH

Cord clamping: Early versus delayed

Referring to the benefits of delayed cord clamping cited in June’s OB/GYN & Pediatrics CCC Corner*:

I would like to refer readers to another study which showed benefits of delayed cord clamping in preterm neonates -

CONCLUSION: The research design is feasible. The immediate benefit of improved blood pressure was confirmed and other findings deserve consideration for further study.

Mercer JS, McGrath MM, Hensman A, Silver H, Oh W. Immediate and delayed cord clamping in infants born between 24 and 32 weeks: a pilot randomized controlled trial. J Perinatol. 2003 Sep;23(6):466-72.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=13679933&query_hl=6

…..and to an excellent review of this topic which concluded that there were benefits of delayed cord clamping in both preterm and full term neonates.

CONCLUSION: For both term and preterm infants, few, if any, risks were associated with delayed cord clamping. Longitudinal studies of infants with immediate and delayed cord clamping are needed.

Mercer JS. Current best evidence: a review of the literature on umbilical cord clamping.
J Midwifery Womens Health. 2001 Nov-Dec;46(6):402-14. Review.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11783688&query_hl=6

OB/GYN CCC Editorial comment:

At this time the comments above are best applied to pre-term delivery as the weight of evidence favors early cord clamping in term delivery.

There are two main approaches to term third stage management

Expectant management — Expectant or physiologic management consists of delivery of the placenta without the use of uterotonic agents, cord clamping, or cord traction.

Active management — Active management generally consists of early cord clamping, controlled cord traction, and administration of a uterotonic agent.

A classic study randomly assigned 1795 women to expectant or active third stage labor management. Actively managed patients

-received 5 IU of oxytocin and 0.5 mg of ergometrine upon delivery of the fetal anterior shoulder

-followed by controlled cord traction.

Almost all women allocated to active management actually received it, while just under one-half of those allocated to physiological management received no intervention. The active management group had a significantly lower incidence of postpartum hemorrhage (6 versus 18 percent) and a shorter median duration of the third stage (5 versus 15 minutes).

A Cochrane review of five studies comparing active versus expectant management of the third stage of labor. Expectant management of the third stage of labour involves allowing the placenta to deliver spontaneously or aiding by gravity or nipple stimulation. Active management involves administration of a prophylactic oxytocic before delivery of the placenta, and usually early cord clamping and cutting, and controlled cord traction of the umbilical cord.

Cochrane found that active management was associated with reduced risks of: maternal blood loss (weighted mean difference -79.33 mL, 95 percent CI -94.29 to -64.37); postpartum hemorrhage of more than 500 mL (relative risk 0.38, 95 percent CI 0.32 to 0.46); and prolonged third stage of labor (weighted mean difference -9.77 minutes, 95 percent CI -10.00 to -9.53). Active management was defined as administration of a prophylactic oxytocic before delivery of the placenta; typically with early cord clamping and cutting and controlled traction of the umbilical cord. The authors concluded that "active management should be the routine management of choice for women expecting to deliver a baby by vaginal delivery in a maternity hospital.

Active management of labor is the most common standard of care for term patients, plus there is recent data from Indian Country to support active management of term third stage of labor in Indian Health. http://www.ihs.gov/MedicalPrograms/MCH/M/obgyn0705_Feat.cfm#navajo

Resources

Prendiville WJ; Elbourne D; McDonald S Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000;(3):CD000007.

http://www.update-software.com/cochrane/abstract.htm

Prendiville WJ; Harding JE; Elbourne DR; Stirrat GM The Bristol third stage trial: active versus physiological management of third stage of labour. BMJ 1988 Nov 19;297(6659):1295-300.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3144366&query_hl=12

Rabe H, et al. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004;(3):CD003248

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15495045&query_hl=6

Chuck North, Albuquerque

Advances in Indian Health, 6th Annual

Save the dates brochure
http://www.ihs.gov/MedicalPrograms/MCH/M/documents/Advancesflyer2006.pdf

Miles Rudd, Warm Springs, OR

Relative value of physical exam of the breast as a screening tool

Miles Rudd at Warm Springs, OR raised the issue of the relative value of physical exam of the breast exam in cancer screening.

Here are some brief bulleted points for Dr. Eve Espey’s presentation on Breast Cancer at the 2005 IHS / ACOG Obstetric, Neonatal and Gynecologic Care Postgraduate Course. More complete discussion below.

Breast self exam (BSE) Canadian Task Force on Prevention*

Fair evidence of no benefit

Good evidence of harm

Overall fair evidence that routine teaching of BSE should be excluded from the annual exam

  • D recommendation

USPSTF: 2002, Should we recommend BSE?

BSE: insufficient evidence to recommend for or against

  • “I” recommendation

Studies evaluating BSE

  • 2 RCTs, 1 quasi RCT, 3 case-control studies
  • No difference in breast cancer mortality
  • No difference in stage of cancer at diagnosis
  • More provider visits: 8% vs. 4%
  • More benign biopsies

ACOG Practice Bulletin: Breast cancer screening, April, 2003

Despite a lack of definitive data for or against breast self-examination, breast self-examination has the potential to detect palpable breast cancer and can be recommended.

Costs of BSE

  • $700 per competent frequent self-examiner
  • Opportunity cost: limited time for counseling
  • Anxiety, worry, depression

Summary

  • Take down your shower card for BSE
  • Encourage mammography
  • Work up palpable masses
  • Don’t worry quite so much…

OB/GYN CCC Editorial comment:

The data shows that the foundation of any breast cancer screening effort is a comprehensive mammography based program. The history and physical examination are an important adjuncts to screening, but should not delay, or become barriers to mammography. An equally important public health systems ‘process’ is a robust follow-up system. The RPMS Women’s Health Program, or other tracking system software packages, can be critical to maintaining adequate screening follow up.

What is the Indian Health Manual suggested approach? National benchmarks?

The Indian Health Manual suggested approach is based on mammography and is compatible with national benchmarks. The article referenced below is a good summary of the national benchmarks, though is not entirely internally consistent. The first part of the article articulates the limitations of the data on clinical breast exam (CBE). The second part (their ‘Recommendations’) is essentially a primer on performing the extensive Mammacare exam.

Though Mammacare has been shown to find more lesions during the lengthy exam, the increased detection of non-malignant lesions does not improve breast cancer outcomes.

Saslow D, et al Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin. 2004 Nov-Dec;54(6):327-44
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15537576&query_hl=2

The above are just a few of Dr. Espey’s many helpful points. The whole presentation is here: http://www.ihs.gov/MedicalPrograms/MCH/M/documents/BreastCa2005.ppt

or

Please also see the Reference Text Chapter from the Postgraduate Course

http://www.ihs.gov/medicalprograms/MCH/M/MCHdownloads/Chap_P.pdf?page=2

IHS Manual Part 3 – Chapter 13.11F1

“Resources for screening mammography should be identified for patients at increased risk for breast cancer as based upon age as well as other personal and familial risk factors.”

http://www.ihs.gov/PublicInfo/Publications/IHSManual/Part3/pt3chapt13/pt3chpt13.htm

IHS Women’s Health Breast Cancer web page

../W/WHcancer.asp#breast

*USPSTF and Canadian TFPHC Rating of evaluations

A: Strong recommendation to include the service

B: Recommendation to include the service

C: No recommendation either for or against

D: Recommendation against routine provision of the service

I: Evidence insufficient

Jennifer Retsinas, ANMC

Uterine fibroids: uterine artery embolization versus abdominal hysterectomy

CONCLUSION: Compared with hysterectomy, UAE is safe and effective for treatment of bleeding fibroids, necessitates a shorter hospital stay, and results in fewer major complications

Pinto I, et al Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment--a prospective, randomized, and controlled clinical trial. Radiology. 2003 Feb;226(2):425-31.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12563136&query_hl=6

Phil Smith, HQE

New Outreach: Updated educational materials about the Prescription Drug Benefit

http://www.cms.hhs.gov/medicarereform/factsheets.asp

Judy Thierry, HQE

Many girls are at a literal standstill

Decline in physical activity plays key role in weight gain among adolescent girls

http://www.nih.gov/news/pr/jul2005/nhlbi-13.htm

Trends and Regional Differences: Latest available

It has come to my attention that some of you do not have the latest Trends and Regional Differences publications produced by our Statistics Branch. The 2000-2001 Trends and Regional Differences contains data from 1996-1998. They are not online, hence you need to order the mailed publications. If you would like to order them, please go to https://propshop.psc.gov/ and begin by clicking the Product Distribution link.

Contact dsaum@psc.gov for any problems with ordering.
NB: Tribal and Seattle Urban program would follow under the '50 states category'. Please call us (DPS) at 301-443-1180 or Priscilla Sandoval 301-443-9436. We will provide your UserID and password.

Great resource: MCH Alert

If you have not subscribed to this list serve the link is below at the end of the email and here as well.

To subscribe to MCH Alert, send an e-mail message to MCHAlert-request@list.ncemch.org

with SUBSCRIBE in the subject line. You do not need to enter any text in the body of the message.

”Weaving WIC into Our Traditional Families”

National Indian and Native American Coalition August 27-30, 2005 Tempe, Arizona

http://www.itcaonline.com/event008/eventreg.html

Child Protection Handbook 2004, IHS/BIA

IHS Office of Behavioral Health - BIA funded the development of a CD ROM

http://www.ccan.ouhsc.edu/nativeamerican.asp or http://www.ccan.ouhsc.edu/CPT.htm

Carol Treat, Nutritionist, ANMC

Brochure/support for sugar substitute and gestational DM

http://www.ific.org/publications/brochures/upload/gestationaldiabetes.pdf

Back to top

OB/GYN

Dr. Neil Murphy is the Obstetrics and Gynecology Chief Clinical Consultant (OB/GYN C.C.C.). Dr. Murphy is very interested in establishing a dialogue and/or networking with anyone involved in women's health or maternal child health, especially as it applies to Native or indigenous peoples around the world. Please don't hesitate to contact him by e-mail or phone at 907-729-3154.

This file last modified: Monday June 16, 2008  10:33 AM